Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Aligos Therapeutics ( (ALGS) ) is now available.
On January 30, 2025, Aligos Therapeutics appointed Lesley Ann Calhoun as Chief Operating Officer while she retains her role as Chief Financial Officer. This strategic appointment aims to leverage her extensive financial and operational experience, potentially strengthening the company’s leadership and operational efficiency.
More about Aligos Therapeutics
YTD Price Performance: -35.21%
Average Trading Volume: 477,884
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $92.57M
See more data about ALGS stock on TipRanks’ Stock Analysis page.
